According to the 5th edition of the WHO classification, the required diagnostic criteria for fumarate hydratase-deficient renal cell carcinoma (FH-RCC) include immunohistochemical evidence of FH germline or somatic mutation, or FH deficiency, defined by loss of FH protein expression and/or positive 2SC staining. This evidence concerns the gene FH and renal cell carcinoma.